What do systematic reviews say?

24 questions · 24 findings · 9 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 24 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

NB‐UVB vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

UVA1 vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs placebo

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Methotrexate vs other DMARDs

Health‐related quality of life ‐ not measured · psoriatic arthritis

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for psoriatic arthritis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rilonacept vs indomethacin

Health‐related quality of life ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Canakinumab vs triamcinolone acetonide

Health‐related quality of life ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo

Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease

The review found no eligible studies for this question.

1 finding from 1 review

Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs Western medicine

Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease

The review found no eligible studies for this question.

1 finding from 1 review

Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life ‐ not measured · patients with acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Lifestyle interventions for acute gout 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Paliperidone palmitate vs placebo

Health‐related quality of life ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Metformin + megestrol vs megestrol

HRQOL ‐ not measured · endometrial hyerplasia

The review found no eligible studies for this question.

1 finding from 1 review

Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs megestrol

HRQOL ‐ not measured · endometrial hyperplasia

The review found no eligible studies for this question.

1 finding from 1 review

Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Flutamide 250 mg once to b.i.d. vs spironolactone 100 mg

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethinyl estradiol 35 μg + cyproterone acetate 2 mg vs ethinyl estradiol 30 μg + desogestrel 0.15 mg

Change in health‐related quality of life (HRQOL) ‐ not measured · patients with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Spironolactone 100 mg vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Finasteride 5 mg to 7.5 mg vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin 500 mg to 2550 mg per day vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Finasteride 5 mg vs spironolactone 100 mg

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Flutamide 250 mg once to b.i.d. vs metformin 1275 mg to 1700 mg per day

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Finasteride 5 mg vs flutamide 250 mg once to b.i.d.

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found